CloseHelpPrint
Kies de Nederlandse taal
Course module: FA-MA216
FA-MA216
Pharmaceutical policy analysis
Course infoSchedule
Course codeFA-MA216
ECTS Credits7.5
Category / LevelM (Master)
Course typeCourse
Language of instructionDutch
Offered byFaculty of Science; School of Pharmacy, fac. Betawetenschappen;
Contact persondr. A.K. Mantel-Teeuwisse
Telephone+31 622736017
E-mailA.K.Mantel@uu.nl
Lecturers
Contactperson for the course
dr. A.K. Mantel-Teeuwisse
Other courses by this lecturer
Teaching period
2.1  (12/11/2018 to 14/12/2018)
Teaching period in which the course begins
2.1/  4.1
Time slot-: Not in use
Study mode
Full-time
Enrolment periodfrom 17/09/2018 up to and including 30/09/2018
Course application processstudentenbalie
Enrolling through OSIRISYes
Enrolment open to students taking subsidiary coursesYes
Pre-enrolmentNo
Waiting listNo
Course placement processStudiepunt/Student desk
Aims
After this course the student is able to
  1. Interpret commonly used frameworks for access to medicines;
  2. Explain which factors and which stakeholders are involved in ensuring timely access to medicines;
  3. Analyse enablers and barriers of access to medicines in different settings (e.g. income level, geographical region, jurisdiction), especially with respect to regulation, pricing and reimbursement and responsible use of medicines;
  4. Understand different analytical approaches to assess access to medicines;
Develop a research protocol for a pharmaceutical policy analysis.
Content
Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments.
Inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place. Access to medicines is part of the fulfillment of the right to health, but worldwide many people lack appropriate access. Pharmaceutical policy analysis may provide the much needed evidence to inform policy and decision makers involved in ensuring access to medicines from bench to bedside.
 
In this course, students will gain insight in the framework(s) defining access to medicines and all stakeholders involved. The course will specifically focus on Regulation, Pricing & reimbursement and Responsible use. Furthermore, students will develop a better understanding of analytical approaches in pharmaceutical policy analysis using these three themes as learning devices.

 
Competencies
-
Entry requirements
Prerequisite knowledge
This course is open to master students Pharmacy, Drug Innovation, other research master GS-LS, other health related masters (e.g. medicine, veterinary medicine, health law)
Required materials
-
Instructional formats
Lecture

Seminar

Tests
Final result
Test weight100
Minimum grade-

Assessment
Group assignment – 50% of final grade, minimum = 5,5
Individual exam – 50% of final grade, minimum = 5,5

CloseHelpPrint
Kies de Nederlandse taal